Financhill
Buy
68

CAC Quote, Financials, Valuation and Earnings

Last price:
$42.74
Seasonality move :
0%
Day range:
$42.44 - $43.13
52-week range:
$34.53 - $47.55
Dividend yield:
3.93%
P/E ratio:
12.19x
P/S ratio:
1.99x
P/B ratio:
1.07x
Volume:
89.6K
Avg. volume:
70.3K
1-year change:
-8.12%
Market cap:
$723.8M
Revenue:
$293.8M
EPS (TTM):
$3.51

CAC Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for Camden National Corp. (Maine) shares anticipate an average target of $46.50, ranging from a low estimate of $44.00 to a high estimate of $53.00. This average target implies a growth of 8.72% compared to the current stock price of $42.77.

Consensus Price Target

$46.50

Highest Price Target

$53.00

Lowest Price Target

$44.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 1

Hold 0 0 2

Sell 0 0 0
Consensus -- -- Hold

CAC Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
72
KYMR alert for Dec 8

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock